In 2011, hc1 Insights™ (hc1) was created because our founder recognized that if labs could organize the vast amounts of powerful data they produce into actionable insights, they could be empowered to better manage operations, as well as personalize and advance care for all patients.
Now more than 10 years later, hc1 is the leader in identifying insights and risk signals from complex laboratory data to optimize patient care, improve operations, reduce supply chain costs and generate profitable growth.
hc1 solutions empower thousands of laboratory locations to leverage the insights within their own data to optimize operations and inform testing and treatment decisions for millions of patients. The hc1 Lab Insights Platform™ organizes diagnostic data for over 90 million patients and processes more than 30 billion clinical transactions and 500 million test results per month. This high performance, high availability, multi-tenant, secure cloud platform optimized to support the needs of high-volume healthcare organizations is powered by Amazon Web Services (AWS).
Security is a priority in every system and service we deliver, and in all business processes we follow. hc1.com Inc. (now, hc1 Insights, Inc.), the hc1 Platform, and the corporate headquarters located in Indianapolis, IN, meet the HITRUST CSF® v9.3 Risk-based, 2-year (r2) certification criteria.
Over the years, our flagship solutions, now known as hc1 Performance Analytics™ and hc1 Operations Management™, have helped us forge a broad set of lab and health system partnerships. Their ability to unlock actionable, real-time insights to increase efficiency and reduce costs continues to be enhanced and expanded through updates and add-on solutions like hc1 Rapid Response Queue™ and hc1 Sendout Management™.
In 2018 we introduced hc1 PrecisionDx Advisor™ because empowering independent and health system laboratory leaders with the insights they need to guide appropriate test utilization enables them to take effective action to ensure the right tests for the right patients. Laboratorians are respected experts on laboratory testing. With a wealth of laboratory data, labs can offer their clinician customers more than just a result. They can offer them a strategy for improved patient care.
In 2022 hc1 began providing insights to the pharma industry by identifying signals in lab, EHR and claims data to match precise patient needs with optimal therapies by clinicians, driving precision diagnostics and patient outcomes.
Most recently, in 2024, hc1 acquired Accumen, a best-in-class healthcare performance consulting company. The acquisition positions hc1 as the only comprehensive solution for transforming diagnostic labs into strategic assets for health systems.
Together, hc1 and Accumen will accelerate healthcare progress by harnessing the power of lab data to generate insights that improve patient care, streamline operations and reduce costs, all while achieving healthy growth to enhance financial performance.
